[85]
The Applicants argue that the invention of the '080 patent is "the S(-) enantiomer of ofloxacin and its analogues having excellent antimicrobial activity". While also asserting that the '080 patent is directed to the combination of higher activity, lower toxicity and higher solubility of levofloxacin.